The efficacy of Momordica charantia L. (herbal agent) in treatment of type 1 diabetes mellitus in rats in comparison to insulin (animal model)
Keywords:
Momordica charantia L, alloxan, insulin, hyperglycemia, hypoglycemiaAbstract
This study was done for a total (24) Black Rats, over a time of 28 days (divided into 1st, 7th. 14th and 28th day) in which (6) Rats in each group, which reflects that ALLOXAN can be caused hyperglycemia with highly significant results (P<0.0001). This increased in blood glucose level can be corrected by HERBAL DRUGS (Momordica Charantia L), with high significant effects (P<0.0001), when compared this with insulin which had high significant results in control hyperglycemia of Alloxan causes (P<0.0001).
Downloads
References
"BSBI List 2007". Botanical Society of Britain and Ireland. Archived from the original (xls) on 2014-10-23. Retrieved 2014-10-17.
Bagchi, Indrani (11 April 2005). "Food for thought: Green 'karela' for Red China". Times of India.
F.J. Breteler, G.H. de Bruijn, et al: Goya Dry by Helios brewery of Okinawa, Department of Plant Taxonomy, Agricultural University, Wageningen (1984).
Lim, T. K. (2013). Edible medicinal and non-medicinal plants. Dordrecht: Springer. pp. 331–332. ISBN 9789400717640
Bitter Melon". Memorial Sloan-Kettering Cancer Center. Retrieved 17 October 2013.
Bachok, M. F.; Yusof, B. N.; Ismail, A; Hamid, A. A. (2014). "Effectiveness of traditional Malaysian vegetables (ulam) in modulating blood glucose levels" (PDF). Asia Pacific Journal of Clinical Nutrition. 23 (3): 369–76.
Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes— systematic overview of prospective observational studies. Diabetologia. 2005 Dec 8; 48(12):2460–9.↵
Banerjee S, Sinharoy K, Singh AK. Oral hypoglycaemic agent failure. J Indian Med Assoc. 2002 Jul; 100(7):452–6.
Chawla R, Thakur P, Chowdhry A, Jaiswal S, Sharma A, Goel R, et al. Evidence based herbal drug standardization approach in coping with challenges of holistic management of diabetes : A dreadful J Diabetes &Metabolic Disord. 2013; 12(35):116.
"Bitter Melon". Memorial Sloan-Kettering Cancer Center. Retrieved 17 October 2013.
Mrozikiewicz, A.; Kielstrokczewska-Mrozikiewicz, D.; Lstrokowicki, Z.; Chmara, E.; Korzeniowska, K.; Mrozikiewicz, P. M. (1994). "Blood Levels of Alloxan in Children with Insulin-dependent Diabetes Mellitus". Acta Diabetologica. 31 (4): 236–237. doi:10.1007/bf00571958. PMID 7888696.
Danilova I.G., Sarapultsev P.A., Medvedeva S.U., Gette I.F., Bulavintceva T.S., Sarapultsev A.P. (2014). "Morphological Restructuring of Myocardium during the Early Phase of Experimental Diabetes Mellitus". Anat. Rec. 298 (2): 396–407. doi:10.1002/ar.23052. hdl:10995/73117.
Loreto D, Elina V. 2009. Experimental surgical models in the laboratory rat. Boca Raton: CRC Press.
Szkudelski T (2001). "The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas". Physiol Res. 50: 536–546.
Tyrberg, B.; Andersson, A.; Borg, L. A. (2001). "Species Differences in Susceptibility of Transplanted and Cultured Pancreatic Islets to the β-Cell Toxin Alloxan". General and Comparative Endocrinology. 122 (3): 238–251. Doi:10.1006/gcen.2001.7638. PMID 11356036.
Eizirik, D. L.; Pipeleers, D. G.; Ling, Z.; Welsh, N.; Hellerström, C.; Andersson, A. (1994). "Major Species Differences between Humans and Rodents in the Susceptibility to Pancreatic β-Cell Injury". Proceedings of the National Academy of Sciences of the United States of America. 91 (20): 9253–9256.
Leiter and Schile, "The Main action and toxic effect of alloxan and streptozotocin action in B cells of the rat pancreas". Physiol Res. 50: 536–546.2013
Szkudelski T, “Susceptible dose effect the beta-cell of pancrease to induce hypoglycemia” General and Comparative Endocrinology. 122 (3): 238–251. doi:10.1006/gcen.2001.
Szkudelski et al., “The effect of alloxan on blood sugar level, Proceedings of the National Academy of Sciences of the United States of America. 65 (15): 7253–7256) 1998.
Brentjens R, Saltz L (2001). "Islet cell tumors of the pancreas: the medical oncologist's perspective". Surg Clin North Am. 81 (3): 527–42.
Leatherdale, B.A.; Panesar, R.K.; Singh, G.; Atkins, T.W.; Bailey, C.T.; Bignell, A.H.C. Improvement in glucose tolerance due to Momordica charantia (karela). Br. Med. J. (Clin. Res. Ed.) 1981, 282, 1823–1824.
Zhao, G.T.; Liu, J.Q.; Deng, Y.Y.; Li, H.Z.; Chen, J.C.; Zhang, Z.R.; Qiu, M.H. Cucurbitane-type triterpenoids from the stems and leaves of Momordica charantia. Fitoterapia 2014, 95, 75–82.
Chang, C.I.; Chen, C.R.; Liao, Y.W.; Cheng, H.L.; Chen, Y.C.; Chou, C.H. Cucurbitane-type triterpenoids from the stems of Momordica charantia. J. Nat. Prod. 2008, 71, 1327–1330.
Ojewole, J.A.; Adewole, S.O.; Olayiwola, G. Hypoglycaemic and hypotensive e_ects of Momordica charantia Linn. (Cucurbitaceae) whole-plant aqueous extract in rats. Cardiovasc. J. Afr. 2006, 17, 227–232. -
Peter, E.; Kasali, F.; Deyno, S.; Mtewa, A.; Nagendrappa, P.; Tolo, C.; Ogwang, P.; Sesaazi, D. Momordica charantia L. lowers elevated glycaemia in type 2 diabetes mellitus patients: Systematic review and meta-analysis. J. Ethnopharmacol. 2019, 231, 311–324.
Nuckols, T.; Keeler, E.; Anderson, L.; Green, J.; Morton, S.; Doyle, B.; Shetty, K.; Arifkhanova, A.; Booth, M.; Shanman, R.; et al. Economic evaluation of quality improvement interventions designed to improve glycemic. Control in diabetes: A systematic review and weighted regression analysis. Diabetes Care 2018, 41, 985–993.
Jia, S.; Shen, M.; Zhang, F.; Xie, J. Recent advances in Momordica charantia: Functional components and biological activities. Int. J. Mol. Sci. 2017, 18, 2555.
Cohn LA, McCaw DL, Tate DJ, Johnson JC. 2000. Assessment of 5 portable blood glucose meters, a point-of-care analyzer, and color test strips for measuring blood glucose concentration in dogs. J Am Vet Med Assoc 216:198–202.
Cengiz E, Tamborlane WV. A tale of two compartments: interstitial versus blood glucose monitoring. Diabetes Technol Ther. 2009; 11(suppl 1):S11-S16. doi:10.1089/dia.2009.0002.
Botanical Society of Britain and Ireland. Archived from the original (xls) on 2014-10-23. Retrieved 2014-10-17.
Danilova I.G., Sarapultsev P.A., Medvedeva S.U., Gette I.F., Bulavintceva T.S., Sarapultsev A.P. (2014). "Morphological Restructuring of Myocardium during the Early Phase of Experimental Diabetes Mellitus". Anat. Rec. 298 (2): 396–407.
Mrozikiewicz, A.; Kielstrokczewska-Mrozikiewicz, D.; Lstrokowicki, Z.; Chmara, E.; Korzeniowska, K.; Mrozikiewicz, P. M. (1994). "Blood Levels of Alloxan in Children with Insulin-dependent Diabetes Mellitus". Acta Diabetologica. 31 (4): 236–237
N. A. Calcutt, M. E. Cooper, T. S. Kern, and A. M. Schmidt, “Therapies for hyperglycaemia-induced diabetic complications: From animal models to clinical trials,” Nature Reviews Drug. Discovery, vol. 8, no. 5, pp. 417–429, 2009.
Wang, Limei; Waltenberger, Birgit; Pferschy-Wenzig, Eva-Maria; Blunder, Martina; Liu, Xin; Malainer, Clemens; Blazevic, Tina; Schwaiger, Stefan; Rollinger, Judith M.; Heiss, Elke H.; Schuster, Daniela; Kopp, Brigitte; Bauer, Rudolf; Stuppner, Hermann; Dirsch, Verena M.; Atanasov, Atanas G. (2014).
Parket Nelson M, Admond K. Farhad, Steven F. Warefoo, “The role of insulin on Beta-cells of injured pancreas J. Mol. Sci. 2019, 17, 1644.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
